David G. Kalergis
2017
In 2017, David G. Kalergis earned a total compensation of $510.5K as Chief Executive Officer at Diffusion Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $81,000 |
|---|---|
| Option Awards | $99,966 |
| Salary | $317,945 |
| Other | $11,613 |
| Total | $510,524 |
Kalergis received $317.9K in salary, accounting for 62% of the total pay in 2017.
Kalergis also received $81K in non-equity incentive plan, $100K in option awards and $11.6K in other compensation.
Rankings
In 2017, David G. Kalergis' compensation ranked 11,781st out of 14,666 executives tracked by ExecPay. In other words, Kalergis earned more than 19.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,781 out of 14,666 | 20th |
Division Manufacturing | 4,639 out of 5,772 | 20th |
Major group Chemicals And Allied Products | 1,694 out of 2,075 | 18th |
Industry group Drugs | 1,404 out of 1,731 | 19th |
Industry Pharmaceutical Preparations | 1,097 out of 1,333 | 18th |
Source: SEC filing on April 30, 2018.
Kalergis' colleagues
We found three more compensation records of executives who worked with David G. Kalergis at Diffusion Pharmaceuticals in 2017.